Skip to main navigation Skip to search Skip to main content

Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma

  • Roland Kaelin
  • , Giorgia Mastrella
  • , Mengzhuo Hou
  • , Min Li
  • , Veit Stoecklein
  • , Nina Zdouc
  • , Marie Volmar
  • , Hrvoje Miletic
  • , Soeren Reinhard
  • , Christel Herold-Mende
  • , Susanne Kleber
  • , Katharina Eisenhut
  • , Gaetano Gargiulo
  • , Michael Synowitz
  • , Angelo Vescovi
  • , Patrick Harter
  • , Josef Penninger
  • , Ernst Wagner
  • , Michel Mittelbronn
  • , Rolf Bjerkvig
  • Dolores Hambardzumyan, Ulrich Schueller, Joerg-Christian Tonn, Josefine Radke, Rainer Glass

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberANGI-03
Pages (from-to)30-30
JournalNeuro-Oncology
Volume21
Issue numberSuppl.6
DOIs
Publication statusPublished - Nov 2019
Event24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS - Phoenix, Arizona, United States
Duration: 22 Nov 201924 Nov 2019

Cite this